本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ACRUX LTD

0.015
+0.0017.14%
成交量:52.09萬
成交額:7,600.00
市值:611.65萬
市盈率:-0.74
高:0.015
開:0.015
低:0.014
收:0.014
52周最高:0.079
52周最低:0.014
股本:4.08億
流通股本:3.00億
量比:1.55
換手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-0.020
每股收益(LYR):-0.020
淨資產收益率:-132.33%
總資產收益率:-60.07%
市淨率:1.79
市盈率(LYR):-0.75

資料載入中...

公司資料

公司名字:
ACRUX LTD
交易所:
ASX
成立時間:
1998
員工人數:
43
公司地址:
103-113, Stanley Street,West Melbourne,Victoria,Australia
郵編:
3003
傳真:
61 3 8379 0101
簡介:
Acrux Limited, together with its subsidiaries, develops and commercializes specialty and generic topical pharmaceuticals in Australia, Switzerland, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.